Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas.
作者信息
Caro J Jaime
机构信息
McGill University, Montreal, Canada.
London School of Economics, London, UK.
出版信息
Pharmacoeconomics. 2023 Feb;41(2):119-121. doi: 10.1007/s40273-022-01225-8. Epub 2022 Dec 2.
Abstract
摘要
相似文献
1
Best Practices: A Collection of Systematic Critical Reviews of Modeling Approaches in Specific Disease Areas.最佳实践：特定疾病领域建模方法的系统批判性综述汇编。
Pharmacoeconomics. 2023 Feb;41(2):119-121. doi: 10.1007/s40273-022-01225-8. Epub 2022 Dec 2.
3
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
4
Interventions to reduce injuries when transferring patients: a critical appraisal of reviews and a realist synthesis.减少患者转运过程中损伤的干预措施：对综述的批判性评价及实在论综合分析
Int J Nurs Stud. 2014 Oct;51(10):1381-94. doi: 10.1016/j.ijnurstu.2014.03.007. Epub 2014 Apr 1.
7
Systematic Review of the Literature: Best Practices.系统文献综述：最佳实践。
Acad Radiol. 2018 Nov;25(11):1481-1490. doi: 10.1016/j.acra.2018.04.025. Epub 2018 Jul 31.
8
Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews.多层面自杀预防策略的最佳实践要素：系统评价综述。
Crisis. 2011;32(6):319-33. doi: 10.1027/0227-5910/a000109.
9
Capture-mark-recapture as a tool for estimating the number of articles available for systematic reviews in critical care medicine.捕获-标记-再捕获法作为一种工具，用于估计重症监护医学系统评价可用文章的数量。
J Crit Care. 2013 Aug;28(4):469-75. doi: 10.1016/j.jcrc.2012.10.071. Epub 2013 Jan 9.
10
引用本文的文献
1
Economic Evaluation of Interventions to Reduce Antimicrobial Resistance: A Systematic Literature Review of Methods.减少抗菌药物耐药性干预措施的经济学评估：方法的系统文献综述
Pharmacoeconomics. 2025 Jun;43(6):631-646. doi: 10.1007/s40273-024-01468-7. Epub 2025 Mar 6.
2
A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models.系统评价评估复发难治性多发性骨髓瘤治疗方法的建模方法：对未来健康经济模型的关键评价和考虑。
Pharmacoeconomics. 2024 Sep;42(9):955-1002. doi: 10.1007/s40273-024-01399-3. Epub 2024 Jun 25.
3
Critical Examination of Modeling Approaches Used in Economic Evaluations of First-Line Treatments for Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations: A Systematic Literature Review.对表皮生长因子受体突变的局部晚期或转移性非小细胞肺癌一线治疗的经济评估中使用的建模方法的批判性审视：一项系统文献综述
Pharmacoeconomics. 2024 May;42(5):527-568. doi: 10.1007/s40273-024-01362-2. Epub 2024 Mar 15.
本文引用的文献
1
PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews.PRISMA 2020 解释和说明：系统评价报告的更新指南和范例。
BMJ. 2021 Mar 29;372:n160. doi: 10.1136/bmj.n160.
2
TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility.技术验证：减少模型错误并提高其可信度的验证清单。
Pharmacoeconomics. 2019 Nov;37(11):1391-1408. doi: 10.1007/s40273-019-00844-y.
3
AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users.AdViSHE：面向决策者和模型使用者的健康经济模型验证评估工具。
Pharmacoeconomics. 2016 Apr;34(4):349-61. doi: 10.1007/s40273-015-0327-2.
4
Whole disease modeling to inform resource allocation decisions in cancer: a methodological framework.整体疾病建模以告知癌症资源分配决策：一种方法学框架。
Value Health. 2012 Dec;15(8):1127-36. doi: 10.1016/j.jval.2012.07.008. Epub 2012 Oct 25.
5
Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.模型化良好的研究实践概述：ISPOR-SMDM 模型化良好的研究实践工作组的报告——1.
Value Health. 2012 Sep-Oct;15(6):796-803. doi: 10.1016/j.jval.2012.06.012.
Zotero 插件